Request Demo
Last update 02 Jan 2025
Fujian Akeylink Biotechnology Co., Ltd
Private Company | Subsidiary Company|
2021|
Fujian Sheng, China
Last update 02 Jan 2025
Overview
Basic Info
Introduction Fujian Akeylink Biotechnology Co., Ltd. operates as a subsidiary under the majority ownership of Fujian Guangshengtang Pharmaceutical Co., Ltd. The company's primary focus lies in the development and marketing of the oral small molecule 3CL protease inhibitor Taierteve GST-HG171 tablets, aimed at combating COVID-19. |
Tags
Infectious Diseases
Respiratory Diseases
Other Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06263959
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
NCT06087055
An Open Labe Study to Evaluate the Drug-Drug Interaction of Itraconazole With GST-HG171/Ritonavir in Healthy Adult Chinese Participants
NCT06084507
Food Effects Study of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants
100 Clinical Results associated with Fujian Akeylink Biotechnology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Fujian Akeylink Biotechnology Co., Ltd
Login to view more data
100 Translational Medicine associated with Fujian Akeylink Biotechnology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
1
Phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free